References
- 1. Mc Nair E, Qureshi M, Prasad K, Pearce C. Atherosclerosis and hypercholesterolemic Age-Rage axis. Int J Angiol. 2016 Jun;25(2):110-6. DOI: 10.1055/s-0035-157075410.1055/s-0035-1570754
- 2. Li Q, Gu W, Ma X, Liu Y, Jiang L, Feng R, et al. Amino acid and biogenic amine profile deviations in an oral glucose tolerance test: a comparison between healthy and hyperlipidaemia individuals based on targeted metabolomics. Nutrients. 2016 Jun;8(6):379. DOI: 10.3390/nu806037910.3390/nu8060379
- 3. Vergeer M, Holleboom AG, Kastelein JJP, Kuivenhoven JA. The HDL hypothesis: does highdensity lipoprotein protect from atherosclerosis? J Lipid Res. 2010 Aug;51(8):2058-73. DOI: 10.1194/jlr.R001610
- 4. Zhao Y, Dai XY, Zhou Z, Zhao GX, Wang X, Xu MJ. Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice. Acta Pharmacol Sin. 2016 Feb;37(2):196-203. DOI: 10.1038/aps.2015.8810.1038/aps.2015.88
- 5. Badimon L, Vilahur G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos. Ann N Y Acad Sci. 2012 Apr;1254:18-32. DOI: 10.1111/j.1749-6632.2012.06480.x10.1111/j.1749-6632.2012.06480.x
- 6. Zhang S, Zeng X, Ren M, Mao X, Qiao S. Novel metabolic and physiological function of branched chain amino acids: a review. J Anim Sci Biotechnol. 2017 Jan;8:10. DOI: 10.1186/s40104-016-0139-z10.1186/s40104-016-0139-z
- 7. Cojocaru E, Zamfir C, Zamosteanu N, Trandafirescu M, Cotuţiu C. The effects of branched chain aminoacids on LDL-cholesterol in experimental animals subjected to dietary hypercholesterolemia. Rev Med Chir Soc Med Nat Iasi. 2012 Jan-Mar;116(1):200-6.
- 8. Yang R, Dong J, Zhao H, Li H, Guo H, et al. Association of Branched-Chain Amino Acids with Carotid Intima-Media Thickness and Coronary Artery Disease Risk Factors. PLoS ONE. 2014 Jun;9(6):e99598. DOI: 10.1371/journal.pone.0099598
- 9. Cojocaru E, Zamfir C, Amihăesei C, Trandafirescu M, Leon M, Mitu F. The influence of branched amino acids on LDL-cholesterol levels in a model of experimental atherosclerosis. Romanian Journal of Functional and Clinical, Macro- and Microscopical Anatomy and of Anthropology 2012;11(1):35-40.
- 10. *** National Research Council of the National Academies. Guide for the Care and Use of laboratory animals. 8th edition. The National Academies Press, Washington, USA, 2011.
- 11. *** Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:en:PDF
- 12. *** The ARRIVE Guidelines - Animal Research: Reporting In Vivo Experiments. Available at http://www.nc3rs.org.uk/page.asp?id=1357.
- 13. Festing MFW, Overend P, Gaines Das R, Cortina Borja M, Berdoy M. The design of animal experiments: reducing the number of animals in research through better experimental design, Laboratory Animal Handbooks Series 14. Royal Society of Medicine Press, London, 2002.
- 14. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of the total cholesterol serum. Clin Chem. 1973 Dec;19(12):1350-6.
- 15. Bennett BJ, Davis RC, Civelek M, Orozco L, Wu J, Qi H et al. Genetic architecture of atherosclerosis in mice: A Systems Genetics Analysis of Common Inbred Strains. PLoS Genet. 2015 Dec;11(12):e1005711. DOI: 10.1371/journal.pgen.1005711
- 16. Anandhi R, Thomas PA, Geraldine P. Evaluation of the anti-atherogenic potential of chrysin in Wistar rats. Mol Cell Biochem. 2014 Jan;385(1-2):103-13. DOI: 10.1007/s11010-013-1819-z10.1007/s11010-013-1819-z
- 17. Xiao F, Du Y, Ly Z, Chen S, Zhu J, Sheng H, et al. Effects of essential amino acids on lipid metabolism in mice and humans. J Mol Endocrinol. 2016 Nov;57(4):223-231. DOI: 10.1530/JME-16-011610.1530/JME-16-0116
- 18. Kitsy A, Carney S, Vivar JC, Knight MS, Pointer MA. Effects of leucine supplementation and serum withdrawal on branched-chain amino acid pathway gene and protein expression in mouse adipocytes. PLoS One. 2014 Jul;9(7):102615. DOI: 10.1371/journal.pone.0102615
- 19. Miasoedov NF, Shubina TA, Obergan T, Grigorieva ME, Andreeva LA, Liapina LA. Cholesterol-lowering effect of the regulatory peptide Pro-Gly-Pro-Leu. Vopr Pitan. 2013;82(5):41-5.
- 20. Matoba T, Sato K, Egashira K. Mouse models of plaque rupture. Curr Opin Lipidol. 2013 Oct;24(5):419-25. DOI: 10.1097/MOL.0b013e3283646e4d10.1097/MOL.0b013e3283646e4d
- 21. Garjani A, Azarmiy Y, Zakheri A, Allaf Akbari N, Andalib S, Maleki-Dizaji N. Vascular Dysfunction in Short-Term Hypercholesterolemia despite the Absence of Atherosclerotic Lesions. J Cardiovasc Thorac Res. 2011 Aug;3(3):73-7.
- 22. De Brito FCF. Inhibition of inflammatory pathways promotes an improving effect on endothelial dysfunction: The effects of Longxuetongluo capsule in an experimental model of atherosclerosis. Atherosclerosis. 2016 Oct;255:111-2. DOI: 10.1016/j.atherosclerosis. 2016.10.04010.1016/j.atherosclerosis.2016.10.040